Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?Praisy K Prabha, Ajay Prakash, Bikash Medhi
No abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
You can now claim free CME credits for this literature searchClaim now